DNAprint Genomics (DNAG)

[chiggah]

JF,

Yes, true.

Although DNAG now has what I call an investor "apathy factor". So the (tail-end)interest wanes quicker on run-ups whereas even superficial bumps used to attract new investing.

Typically, as the business grows so slowly, so does the impatience of original shareholders, and when metamorphisis finally occurs, many of these people are long gone. The difference here may be that the reverse made so little out of these original holdings, that many did not sell and will get over the intrinsic loss, and eventually witness the success of the company.

Quite a few have averaged down.
The most important step has been taken. The bleeding of new shares has ceased. Now we have 3 M+ in sales next two Q's.

Slowly but surely........